Skip to main content
Midas Edge

PharmaCyte Biotech, Inc.

For the period ended Oct 31, 2025. Filed Dec 18, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Oct 31, 2025 · Filed Dec 18, 2025

PMCB$0.40-1.2%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Unregistered Sales of Equity Securities and Use of Proceeds

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

There were no unregistered sales of the Company’s equity securities during the three months ended October 31, 2025, other than those previously reported in a Current Report on Form 8-K.

Issuer Purchases of Equity Securities

During the three months ended October 31, 2025, there were no purchases of Equity Securities.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.